1. Home
  2. RVSB vs NTHI Comparison

RVSB vs NTHI Comparison

Compare RVSB & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

SELL

Current Price

$6.67

Market Cap

120.5M

Sector

Finance

ML Signal

SELL

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

SELL

Current Price

$4.56

Market Cap

106.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RVSB
NTHI
Founded
1923
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.5M
106.0M
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
RVSB
NTHI
Price
$6.67
$4.56
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
55.5K
★ 157.1K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 1.20%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.18
N/A
Revenue
N/A
★ $39,990.00
Revenue This Year
$42.74
N/A
Revenue Next Year
$5.53
N/A
P/E Ratio
$82.63
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.88
$2.50
52 Week High
$6.67
$11.38

Technical Indicators

Market Signals
Indicator
RVSB
NTHI
Relative Strength Index (RSI) 80.18 69.97
Support Level $5.23 $4.18
Resistance Level N/A $5.79
Average True Range (ATR) 0.14 0.46
MACD 0.05 0.20
Stochastic Oscillator 98.72 69.29

Price Performance

Historical Comparison
RVSB
NTHI

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment. Its operations into two operating segments, consisting of banking operations and trust and investment services, these operating segments are aggregated into a single reportable operating segment.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: